Improving cardiovascular health of patients with chronic kidney disease

The TRACK trial will evaluate whether a small dose of rivaroxaban, a blood-thinning medication, would reduce cardiovascular death or major cardiovascular events in patients with advanced stages of chronic kidney disease.

Under the leadership of @LilyMshar Malaysian sites have randomised 100 patients in @TRACK_trial Congratulations to all the Malaysian investigators and coordinators on this major milestone.

Under the leadership of @vjha126 and @raja_1980 Indian sites have randomised more than 50 patients. Congratulations to all the investigators and coordinators on this milestone.

Load More…